BT PHARMA has two proprietary vaccines platforms:
- CyaA vector system derived from the Adenylate Cyclase (CyaA) protein of the bacteria Bordetella pertussis. Its key property is to induce a strong and specific T cell immune response.
- Peptel® vector system, a ribonucleic complex that can be used either as a vector or/and as a TH1 adjuvant.